Simcere Pharmaceutical Group Limited (HKG:2096)

HKG:2096 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	29,364	17,653	17,611	30,914	23,628	23,347
Market Cap Growth	80.15%	0.24%	-43.03%	30.83%	1.20%	-
Enterprise Value	27,779	15,639	16,205	29,371	23,209	26,834
Last Close Price	11.36	6.98	6.42	10.84	8.23	8.09
PE Ratio	28.96	22.63	22.37	29.38	12.77	29.36
Forward PE	20.41	14.35	12.11	29.04	26.63	18.00
PS Ratio	3.77	2.50	2.42	4.32	3.85	4.36
PB Ratio	3.70	2.35	2.21	3.83	2.98	3.68
P/TBV Ratio	4.70	2.81	2.51	4.16	3.10	3.89
P/FCF Ratio	25.82	16.04	-	27.04	-	-
P/OCF Ratio	19.21	11.93	105.83	20.19	-	203.24
PEG Ratio	-	1.12	1.12	1.12	1.12	-
EV/Sales Ratio	3.57	2.22	2.23	4.11	3.78	5.01
EV/EBITDA Ratio	16.22	10.83	15.90	31.86	44.76	29.79
EV/EBIT Ratio	20.02	12.97	20.69	42.85	81.03	37.66
EV/FCF Ratio	24.42	14.21	-	25.69	-	-
Debt / Equity Ratio	0.17	0.17	0.20	0.21	0.25	0.62
Debt / EBITDA Ratio	0.79	0.84	1.43	1.72	3.50	4.10
Debt / FCF Ratio	1.19	1.17	-	1.49	-	-
Asset Turnover	0.58	0.59	0.61	0.60	0.47	0.51
Inventory Turnover	1.91	1.80	2.84	4.01	3.59	2.94
Quick Ratio	1.53	1.73	1.76	1.69	1.51	1.48
Current Ratio	1.73	2.00	2.10	1.84	1.63	1.85
Return on Equity (ROE)	12.45%	10.26%	9.94%	13.62%	25.41%	19.49%
Return on Assets (ROA)	6.50%	6.33%	4.11%	3.62%	1.38%	4.23%
Return on Invested Capital (ROIC)	19.48%	15.63%	10.83%	10.15%	4.14%	11.15%
Return on Capital Employed (ROCE)	13.90%	12.90%	8.70%	7.80%	3.30%	8.10%
Earnings Yield	3.28%	4.42%	4.47%	3.40%	7.83%	3.41%
FCF Yield	3.87%	6.23%	-2.08%	3.70%	-2.14%	-1.30%
Dividend Yield	1.54%	2.44%	2.74%	1.67%	2.24%	2.20%
Payout Ratio	45.61%	54.76%	58.65%	42.04%	25.96%	-
Buyback Yield / Dilution	4.18%	3.40%	0.45%	-0.34%	-9.14%	-2.03%
Total Shareholder Return	5.72%	5.83%	3.19%	1.32%	-6.91%	0.18%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.